• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经济评估中的事件发生时间分析:评估移植边缘质量肾脏成本效益的建模方法比较

Time-to-event analysis in economic evaluations: a comparison of modelling methods to assess the cost-effectiveness of transplanting a marginal quality kidney.

作者信息

Senanayake Sameera, Graves Nicholas, Healy Helen, Baboolal Keshwar, Barnett Adrian, Kularatna Sanjeewa

机构信息

Australian Centre for Health Services Innovation (AusHSI) and Centre for Healthcare Transformation, Queensland University of Technology (QUT), 60 Musk Ave, Kelvin Grove, QLD, 4059, Australia.

Duke-NUS Medical School, 8 College road, Singapore, Singapore.

出版信息

Health Econ Rev. 2021 Apr 15;11(1):13. doi: 10.1186/s13561-021-00312-4.

DOI:10.1186/s13561-021-00312-4
PMID:33856573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8051030/
Abstract

BACKGROUND

Economic-evaluations using decision analytic models such as Markov-models (MM), and discrete-event-simulations (DES) are high value adds in allocating resources. The choice of modelling method is critical because an inappropriate model yields results that could lead to flawed decision making. The aim of this study was to compare cost-effectiveness when MM and DES were used to model results of transplanting a lower-quality kidney versus remaining waitlisted for a kidney.

METHODS

Cost-effectiveness was assessed using MM and DES. We used parametric survival models to estimate the time-dependent transition probabilities of MM and distribution of time-to-event in DES. MMs were simulated in 12 and 6 monthly cycles, out to five and 20-year time horizon.

RESULTS

DES model output had a close fit to the actual data. Irrespective of the modelling method, the cycle length of MM or the time horizon, transplanting a low-quality kidney as compared to remaining waitlisted was the dominant strategy. However, there were discrepancies in costs, effectiveness and net monetary benefit (NMB) among different modelling methods. The incremental NMB of the MM in the 6-months cycle lengths was a closer fit to the incremental NMB of the DES. The gap in the fit of the two cycle lengths to DES output reduced as the time horizon increased.

CONCLUSION

Different modelling methods were unlikely to influence the decision to accept a lower quality kidney transplant or remain waitlisted on dialysis. Both models produced similar results when time-dependant transition probabilities are used, most notable with shorter cycle lengths and longer time-horizons.

摘要

背景

使用马尔可夫模型(MM)和离散事件模拟(DES)等决策分析模型进行经济评估,在资源分配方面具有很高的价值。建模方法的选择至关重要,因为不恰当的模型会产生可能导致错误决策的结果。本研究的目的是比较使用MM和DES对低质量肾脏移植结果与继续等待肾脏移植进行建模时的成本效益。

方法

使用MM和DES评估成本效益。我们使用参数生存模型来估计MM的时间依赖性转移概率和DES中事件发生时间的分布。MM在12个月和6个月的周期内进行模拟,时间跨度为5年和20年。

结果

DES模型输出与实际数据拟合良好。无论建模方法、MM的周期长度或时间跨度如何,与继续等待相比,移植低质量肾脏是主要策略。然而,不同建模方法在成本、效益和净货币效益(NMB)方面存在差异。6个月周期长度的MM的增量NMB与DES的增量NMB更接近。随着时间跨度的增加,两种周期长度与DES输出的拟合差距减小。

结论

不同的建模方法不太可能影响接受低质量肾脏移植或继续等待透析的决策。当使用时间依赖性转移概率时,两种模型产生相似的结果,在较短的周期长度和较长的时间跨度下最为明显。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/992d40218f9e/13561_2021_312_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/4434d7ff1bcb/13561_2021_312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/e3cbdfd4cd24/13561_2021_312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/cef471b2bf6a/13561_2021_312_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/992d40218f9e/13561_2021_312_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/4434d7ff1bcb/13561_2021_312_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/e3cbdfd4cd24/13561_2021_312_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/cef471b2bf6a/13561_2021_312_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/03da/8051030/992d40218f9e/13561_2021_312_Fig4_HTML.jpg

相似文献

1
Time-to-event analysis in economic evaluations: a comparison of modelling methods to assess the cost-effectiveness of transplanting a marginal quality kidney.经济评估中的事件发生时间分析:评估移植边缘质量肾脏成本效益的建模方法比较
Health Econ Rev. 2021 Apr 15;11(1):13. doi: 10.1186/s13561-021-00312-4.
2
Donor Kidney Quality and Transplant Outcome: An Economic Evaluation of Contemporary Practice.供体肾脏质量与移植结局:当代实践的经济评估。
Value Health. 2020 Dec;23(12):1561-1569. doi: 10.1016/j.jval.2020.07.007. Epub 2020 Sep 15.
3
Matching the model with the evidence: comparing discrete event simulation and state-transition modeling for time-to-event predictions in a cost-effectiveness analysis of treatment in metastatic colorectal cancer patients.将模型与证据相匹配:比较离散事件模拟和状态转移建模在转移性结直肠癌患者治疗的成本效益分析中的时间事件预测。
Cancer Epidemiol. 2018 Dec;57:60-67. doi: 10.1016/j.canep.2018.09.008. Epub 2018 Oct 11.
4
Deceased donor kidney allocation: an economic evaluation of contemporary longevity matching practices.已故供者肾脏分配:对当代寿命匹配实践的经济评估。
BMC Health Serv Res. 2020 Oct 9;20(1):931. doi: 10.1186/s12913-020-05736-y.
5
Comparison of Markov model and discrete-event simulation techniques for HIV.用于艾滋病病毒的马尔可夫模型与离散事件模拟技术的比较。
Pharmacoeconomics. 2009;27(2):159-65. doi: 10.2165/00019053-200927020-00006.
6
Comparing the Net Benefits of Adult Deceased Donor Kidney Transplantation for a Patient on the Preemptive Waiting List vs a Patient Receiving Dialysis.比较预先等待名单上的患者与接受透析治疗的患者进行成人已故供体肾移植的净收益。
JAMA Netw Open. 2022 Jul 1;5(7):e2223325. doi: 10.1001/jamanetworkopen.2022.23325.
7
An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting.在容量受限的医疗保健环境中,马尔可夫队列建模与离散事件模拟的实证比较。
Eur J Health Econ. 2017 Jan;18(1):33-47. doi: 10.1007/s10198-015-0756-z. Epub 2015 Dec 29.
8
Drug-eluting stents: a systematic review and economic evaluation.药物洗脱支架:系统评价与经济学评估
Health Technol Assess. 2007 Nov;11(46):iii, xi-221. doi: 10.3310/hta11460.
9
Screening for Asymptomatic Coronary Artery Disease in Waitlisted Kidney Transplant Candidates: A Cost-Utility Analysis.无症状性冠状动脉疾病在等待肾移植候选人中的筛查:成本-效用分析。
Am J Kidney Dis. 2020 May;75(5):693-704. doi: 10.1053/j.ajkd.2019.10.001. Epub 2019 Dec 4.
10
Calculating when elective abdominal aortic aneurysm repair improves survival for individual patients: development of the Aneurysm Repair Decision Aid and economic evaluation.计算择期腹主动脉瘤修复术何时能提高个体患者的生存率:动脉瘤修复决策辅助工具的开发与经济评估。
Health Technol Assess. 2015 Apr;19(32):1-154, v-vi. doi: 10.3310/hta19320.

引用本文的文献

1
Estimated health outcomes of breast cancer screening in the national breast and cervical cancer early detection program by race/ethnicity.按种族/族裔划分的国家乳腺癌和宫颈癌早期检测项目中乳腺癌筛查的估计健康结果。
Cancer Causes Control. 2025 May 6. doi: 10.1007/s10552-025-02006-2.
2
Different Models, Same Results: Considerations When Choosing Between Approaches to Model Cost Effectiveness of Chimeric-Antigen Receptor T-Cell Therapy Versus Standard of Care.不同模型,相同结果:在选择嵌合抗原受体 T 细胞疗法与标准治疗的模型成本效益方法时需要考虑的因素。
Pharmacoeconomics. 2024 Dec;42(12):1359-1371. doi: 10.1007/s40273-024-01430-7. Epub 2024 Sep 7.
3

本文引用的文献

1
Donor Kidney Quality and Transplant Outcome: An Economic Evaluation of Contemporary Practice.供体肾脏质量与移植结局:当代实践的经济评估。
Value Health. 2020 Dec;23(12):1561-1569. doi: 10.1016/j.jval.2020.07.007. Epub 2020 Sep 15.
2
Deceased donor kidney allocation: an economic evaluation of contemporary longevity matching practices.已故供者肾脏分配:对当代寿命匹配实践的经济评估。
BMC Health Serv Res. 2020 Oct 9;20(1):931. doi: 10.1186/s12913-020-05736-y.
3
Cost-utility analysis in chronic kidney disease patients undergoing kidney transplant; what pays? A systematic review.
Cost-Effectiveness and Budget Impact Analysis of Implementing a 'Soft Opt-Out' System for Kidney Donation in Australia.
在澳大利亚实施“软性自愿选择”肾脏捐献系统的成本效益和预算影响分析。
Appl Health Econ Health Policy. 2022 Sep;20(5):769-779. doi: 10.1007/s40258-022-00747-8. Epub 2022 Jul 18.
4
Real-World Cost-Effectiveness of Late Time Window Thrombectomy for Patients With Ischemic Stroke.缺血性中风患者晚期时间窗血栓切除术的真实世界成本效益
Front Neurol. 2021 Dec 14;12:780894. doi: 10.3389/fneur.2021.780894. eCollection 2021.
5
The potential of Senolytics in transplantation.衰老细胞清除疗法在移植中的潜力。
Mech Ageing Dev. 2021 Dec;200:111582. doi: 10.1016/j.mad.2021.111582. Epub 2021 Oct 1.
肾移植慢性肾病患者的成本效用分析;哪些因素起作用?一项系统评价。
Cost Eff Resour Alloc. 2020 May 19;18:18. doi: 10.1186/s12962-020-00213-z. eCollection 2020.
4
Patient-Level Modeling Approach Using Discrete-Event Simulation: A Cost-Effectiveness Study of Current Treatment Guidelines for Women with Postmenopausal Osteoporosis.基于离散事件模拟的患者水平建模方法:对当前绝经后骨质疏松症女性治疗指南的成本效益研究。
J Manag Care Spec Pharm. 2019 Oct;25(10):1089-1095. doi: 10.18553/jmcp.2019.25.10.1089.
5
Analysis of Distribution of Expanded- and Standard-Criteria Donors and Complications Among Polish Recipients by Kidney Donor Risk Index Value.根据肾脏供体风险指数值分析波兰受者中扩大标准供体和标准标准供体的分布及并发症情况。
Transplant Proc. 2018 Jul-Aug;50(6):1686-1690. doi: 10.1016/j.transproceed.2018.02.132. Epub 2018 Mar 14.
6
When does economic model type become a decisive factor in health technology appraisals? Learning from the expanding treatment options for relapsing-remitting multiple sclerosis.经济模型类型何时会成为卫生技术评估的决定性因素?借鉴复发缓解型多发性硬化症不断增加的治疗选择。
J Med Econ. 2018 Oct;21(10):983-992. doi: 10.1080/13696998.2018.1491007. Epub 2018 Jul 5.
7
An economic assessment of contemporary kidney transplant practice.当代肾移植实践的经济评估。
Am J Transplant. 2018 May;18(5):1168-1176. doi: 10.1111/ajt.14702. Epub 2018 Mar 31.
8
Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System.估算澳大利亚卫生系统的参考增量成本-效果比。
Pharmacoeconomics. 2018 Feb;36(2):239-252. doi: 10.1007/s40273-017-0585-2.
9
Long-term outcome of renal transplantation from octogenarian donors: A multicenter controlled study.高龄供者肾移植的长期预后:一项多中心对照研究。
Am J Transplant. 2017 Dec;17(12):3159-3171. doi: 10.1111/ajt.14459. Epub 2017 Sep 15.
10
Parametric regression model for survival data: Weibull regression model as an example.生存数据的参数回归模型:以威布尔回归模型为例。
Ann Transl Med. 2016 Dec;4(24):484. doi: 10.21037/atm.2016.08.45.